-
ÁñÁ«ÊÓƵ Neurology
Original Investigation
April 1, 2024
Matthew Spotnitz, MD, MPH; Cameron D.ÌýEkanayake, BS; Anna Ostropolets, MD, PhD; Guy M.ÌýMcKhann, MD; Hyunmi Choi, MD, MS; Ruth Ottman, PhD; Alfred I.ÌýNeugut, MD, PhD; George Hripcsak, MD, MS; Karthik Natarajan, PhD; Brett E.ÌýYoungerman, MD, MS
ÁñÁ«ÊÓƵ Neurol. 2024; 81(5):499-506. 10.1001/jamaneurol.2024.0551
This cross-sectional study examines the use of neurodiagnostic testing among patients with drug-resistant epilepsy.
-
JAMA Surgery
Research Letter
April 19, 2023
Connor J.ÌýKinslow, MD; James B.ÌýYu, MD, MHS; David M.ÌýDeStephano, MS; Lisa A.ÌýKachnic, MD; Simon K.ÌýCheng, MD, PhD; Alfred I.ÌýNeugut, MD, PhD, MPH; David P.ÌýHorowitz, MD
free access
JAMA Surg. 2023; 158(7):769-771. 10.1001/jamasurg.2023.0262
This cohort study uses national surveillance data to describe the incidence and risk of squamous cell carcinoma after postmastectomy implant reconstruction in women with breast cancer.
-
ÁñÁ«ÊÓƵ Network Open
Research Letter
Hematology
November 22, 2022
Connor J.ÌýKinslow, MD; David M.ÌýDeStephano; Christine H.ÌýRohde, MD, FACS; Lisa A.ÌýKachnic, MD; Simon K.ÌýCheng; Alfred I.ÌýNeugut, MD, PhD; David P.ÌýHorowitz, MD
open access
ÁñÁ«ÊÓƵ Netw Open. 2022; 5(11):e2243396. 10.1001/jamanetworkopen.2022.43396
This cohort study examines the risk of anaplastic large cell lymphoma (ALCL) following postmastectomy implant reconstruction among US women with breast cancer and ductal carcinoma in situ (DCIS).
-
JAMA Oncology
Research Letter
July 21, 2022
Connor J.ÌýKinslow, MD; Arreum Kim, MS, MSBS; Gloria I.ÌýSanchez, PhD; Simon K.ÌýCheng, MD, PhD; Lisa A.ÌýKachnic, MD; Alfred I.ÌýNeugut, MD, PhD, MPH; David P.ÌýHorowitz, MD
free access
JAMA Oncol. 2022; 8(9):1354-1356. 10.1001/jamaoncol.2022.2624
This cohort study of data from the Surveillance, Epidemiology, and End Results 18 database examines the incidence of anaplastic large-cell lymphoma of the breast in the US from 2000 to 2018.
-
ÁñÁ«ÊÓƵ Network Open
Original Investigation
Obstetrics and Gynecology
December 9, 2020
Claire J.ÌýTobias, MD; Ling Chen, MD, MPH; Alexander Melamed, MD, MPH; Caryn St Clair, MD; Fady Khoury-Collado, MD; Ana I.ÌýTergas, MD; June Y.ÌýHou, MD; Chin Hur, MD, MPH; Cande V.ÌýAnanth, PhD, MPH; Alfred I.ÌýNeugut, MD, PhD; Dawn L.ÌýHershman, MD; Jason D.ÌýWright, MD
open access
ÁñÁ«ÊÓƵ Netw Open. 2020; 3(12):e2028612. 10.1001/jamanetworkopen.2020.28612
This cohort study uses data from the National Cancer Database to investigate the association of neoadjuvant therapy with overall survival in women with metastatic endometrial cancer.
-
JAMA Oncology
Research Letter
May 17, 2018
Melissa K.ÌýAccordino, MD; Jason D.ÌýWright, MD; Sowmya Vasan, MS; Donna L.ÌýBuono, MS; Jim C.ÌýHu, MD, MPH; Alfred I.ÌýNeugut, MD, PhD; Dawn L.ÌýHershman, MD, MS
free access
JAMA Oncol. 2018; 4(7):996-998. 10.1001/jamaoncol.2018.0818
This study evaluates the efficacy of an alert in the electronic health record to reduce overuse of granulocyte colony-stimulating factor in older patients hospitalized with febrile neutropenia.
-
JAMA Oncology
Original Investigation
October 1, 2016
Alfred I.ÌýNeugut, MD, PhD; Xiaobo Zhong, MS; Jason D.ÌýWright, MD; Melissa Accordino, MD; Jingyan Yang, MHS; Dawn L.ÌýHershman, MD, MS
free access
JAMA Oncol. 2016; 2(10):1326-1332. 10.1001/jamaoncol.2016.1291
This cohort study uses a large population of women with nonmetastatic breast cancer from the MarketScan database to examine whether adherence to medications for 6 chronic conditions is associated with adherence to adjuvant hormonal therapy.
-
JAMA Surgery
Original Investigation
July 1, 2016
Jason D.ÌýWright, MD; Ana I.ÌýTergas, MD; June Y.ÌýHou, MD; William M.ÌýBurke, MD; Ling Chen, MD, MPH; Jim C.ÌýHu, MD, MPH; Alfred I.ÌýNeugut, MD, PhD; Cande V.ÌýAnanth, PhD, MPH; Dawn L.ÌýHershman, MD
free access
JAMA Surg. 2016; 151(7):612-620. 10.1001/jamasurg.2015.5508
This study evaluates associations between measures of hospital competition and financial status and the proportion of radical prostatectomies, nephrectomies, hysterectomies, and oophorectomies that were robotic-assisted.
-
JAMA Oncology
Original Investigation
September 1, 2016
Heather Greenlee, ND, PhD; Alfred I.ÌýNeugut, MD, PhD; Laura Falci, MPH; Grace Clarke Hillyer, EdD; Donna Buono, MS; Jeanne S.ÌýMandelblatt, MD, MPH; Janise M.ÌýRoh; Isaac J.ÌýErgas, MPH; Marilyn L.ÌýKwan, PhD; Marion Lee, PhD; Wei Yann Tsai, PhD; Zaixing Shi, MS; Lois Lamerato, PhD; Lawrence H.ÌýKushi, ScD; Dawn L.ÌýHershman, MD, MS
free access
JAMA Oncol. 2016; 2(9):1170-1176. 10.1001/jamaoncol.2016.0685
This multisite cohort study of 685 women younger than 70 years with nonmetastatic invasive breast cancer explores whether complementary and alternative medicine use is associated with decreased breast cancer chemotherapy initiation.
-
JAMA Oncology
Viewpoint
April 1, 2016
Alfred I.ÌýNeugut, MD, PhD; Cary P.ÌýGross, MD
JAMA Oncol. 2016; 2(4):421-422. 10.1001/jamaoncol.2016.0328
This Viewpoint evaluates prevention as a component of cancer research.
-
JAMA Oncology
Comment & Response
January 1, 2016
Holly G.ÌýPrigerson, PhD; Alfred I.ÌýNeugut, MD, PhD; Paul K.ÌýMaciejewski, PhD
JAMA Oncol. 2016; 2(1):144-144. 10.1001/jamaoncol.2015.4111
-
JAMA Oncology
Original Investigation
September 1, 2015
Holly G.ÌýPrigerson, PhD; Yuhua Bao, PhD; Manish A.ÌýShah, MD; M. Elizabeth Paulk, MD; Thomas W.ÌýLeBlanc, MD, MA; Bryan J.ÌýSchneider, MD; Melissa M.ÌýGarrido, PhD; M. Carrington Reid, MD, PhD; David A.ÌýBerlin, MD; Kerin B.ÌýAdelson, MD; Alfred I.ÌýNeugut, MD, PhD; Paul K.ÌýMaciejewski, PhD
open access
JAMA Oncol. 2015; 1(6):778-784. 10.1001/jamaoncol.2015.2378
This multi-institutional, longitudinal cohort study finds that palliative chemotherapy did not improve quality of life near death for cancer patients with moderate or poor performance status and worsened quality of life near death for cancer patients with good performance status.
-
JAMA Oncology
Original Investigation
April 1, 2015
Jason D.ÌýWright, MD; Ana I.ÌýTergas, MD; Rosa Cui, BS; William M.ÌýBurke, MD; June Y.ÌýHou, MD; Cande V.ÌýAnanth, PhD, MPH; Ling Chen, MD, MPH; Catherine Richards, PhD; Alfred I.ÌýNeugut, MD, PhD; Dawn L.ÌýHershman, MD
free access
JAMA Oncol. 2015; 1(1):69-77. 10.1001/jamaoncol.2014.206
The prevalence of cancer and precancer of the uterus in women who undergo myomectomy with or without electric power morcellation is low, but risk increases with age, so electric power morcellation should be used with caution in older women undergoing myomectomy.
-
JAMA Oncology
Original Investigation
June 1, 2015
Ellie J.ÌýCoromilas, BA; Jason D.ÌýWright, MD; Yongmei Huang, PhD, MPH; Sheldon Feldman, MD; Alfred I.ÌýNeugut, MD; Ling Chen, MD, MPH; Dawn L.ÌýHershman, MD, MS
free access
JAMA Oncol. 2015; 1(3):323-332. 10.1001/jamaoncol.2015.0389
This cross-sectional study finds that axillary evaluation is often conducted in women treated for ductal carcinoma in situ despite guidelines against its use with breast-conserving surgery and uncertainty of benefit with mastectomy.
-
JAMA Internal Medicine
Invited Commentary
May 1, 2014
Alfred I.ÌýNeugut, MD, PhD
JAMA Intern Med. 2014; 174(5):739-741. 10.1001/jamainternmed.2013.14544
-
JAMA Surgery
Original Investigation
August 1, 2013
Megan Winner, MD, MS; Stephen J.ÌýMooney, MS; Dawn L.ÌýHershman, MD; Daniel L.ÌýFeingold, MD; John D.ÌýAllendorf, MD; Jason D.ÌýWright, MD; Alfred I. Neugut, MD, PhD
free access
JAMA Surg. 2013; 148(8):715-722. 10.1001/jamasurg.2013.1
Winner et al conducted a large population-based study to investigate the incidence and risk factors associated with bowel obstruction in elderly patients with stage IV colon cancer. An invited critique by Krouse follows.
-
JAMA
Editorial
July 24, 2013
Jeanne S. Mandelblatt, MD, MPH; Vanessa B.ÌýSheppard, PhD; Alfred I. Neugut, MD, PhD
JAMA. 2013; 310(4):376-377. 10.1001/jama.2013.8273
-
JAMA Internal Medicine
Original Investigation
Health Care Reform
April 8, 2013
Jason D. Wright, MD; Alfred I. Neugut, MD, PhD; Cande V. Ananth, PhD; Sharyn N. Lewin, MD; Elizabeth T. Wilde, PhD; Yu-Shiang Lu, MS; Thomas J. Herzog, MD; Dawn L. Hershman, MD
free access
JAMA Intern Med. 2013; 173(7):559-568. 10.1001/jamainternmed.2013.2921
To examine compliance with guideline-based recommendations for febrile neutropenia treatment, explore the factors that influence adherence to consensus guidelines, and analyze how the use of guideline-based care effects the outcome Wright and colleagues reviewed the Perspective database entries of 25 231 cancer patients with febrile neutropenia. See invited commentary by Chen.
-
JAMA
Original Contribution
February 20, 2013
Jason D. Wright, MD; Cande V. Ananth, PhD, MPH; Sharyn N. Lewin, MD; William M. Burke, MD; Yu-Shiang Lu, MS; Alfred I. Neugut, MD, PhD; Thomas J. Herzog, MD; Dawn L. Hershman, MD
free access
has multimedia
JAMA. 2013; 309(7):689-698. 10.1001/jama.2013.186
Wright and coauthors examined the use of robotically assisted hysterectomy, its complication profile, and its costs compared with other routes of hysterectomy by performing a cohort study of women who underwent hysterectomy for benign gynecologic disorders from 2007 to 2010. In an Editorial, Weissman and Zinner discuss comparative effectiveness research and robotic surgery.
-
JAMA
Letters
November 10, 2010
Alfred I. Neugut, MD, PhD; Benjamin Lebwohl, MD, MS
JAMA. 2010; 304(18):2016-2018. 10.1001/jama.2010.1586